Carisma Therapeutics
CARM
CARM
27 hedge funds and large institutions have $11M invested in Carisma Therapeutics in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
3
Reduced
4
Closed
7
Calls
–
Puts
$63K
Net Calls
-$63K
Net Calls Change
-$63K
Top Buyers
1 |
HCM
Highbridge Capital Management
New York
|
$1.67M |
2 |
SM
Sabby Management
Miami Beach,
Florida
|
$1.29M |
3 |
KCM
Kingdon Capital Management
New York
|
$1.27M |
4 |
Millennium Management
New York
|
$258K |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$459K |